Heron Therapeutics Inc. buy Quitte
Start price
19.03.18
/
50%
€24.99
Target price
19.07.18
€34.28
Performance (%)
38.63%
End price
19.07.18
€34.64
Summary
This prediction ended on 19.07.18 with a price of €34.64. With a performance of 38.63% the BUY prediction by Quitte was a big success. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Heron Therapeutics Inc. | -12.346% | -12.346% | -65.830% | -65.516% |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % | 57,85 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % | 84,82 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % | 54,81 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % | 64,03 % |
Comments by Quitte for this prediction
In the thread Heron Therapeutics Inc. diskutieren
positive Phase 3
http://www.proactiveinvestors.com/companies/news/193393/heron-therapeutics-reports-positive-phase-3-trials-results-of-anesthetic-sending-shares-soaring-193393.html